A Prospective Masked Clinical Assessment of Inflammation After Intravitreal Injection of Ranibizumab or Aflibercept.

Saved in:
Bibliographic Details
Title: A Prospective Masked Clinical Assessment of Inflammation After Intravitreal Injection of Ranibizumab or Aflibercept.
Authors: Khanani AM; 1 Sierra Eye Associates , Reno, Nevada., Cohen GL; 1 Sierra Eye Associates , Reno, Nevada., Zawadzki R; 2 GISS Enterprises , San Francisco, California.
Source: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2016 May; Vol. 32 (4), pp. 216-8. Date of Electronic Publication: 2016 Mar 03.
Publication Type: Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Association For Ocular Pharmacology And Therapeutics Country of Publication: United States NLM ID: 9511091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7732 (Electronic) Linking ISSN: 10807683 NLM ISO Abbreviation: J Ocul Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-7732
DOI:10.1089/jop.2015.0152